IP Rights, Benefit Sharing And R&D Dominate Talks On WHO Pandemic Treaty
A lot of work needs to be done, and many compromises struck, if talks on the proposed pandemic accord are to be completed in time for the May 2024 deadline.
You may also be interested in...
Members of the European Parliament were told that once the list was out, work would begin on identifying the products most vulnerable to supply chain problems.
Members of the European Parliament committee charged with leading the negotiations on the review of the EU pharmaceutical legislation have been presented with a study backing cuts in data protection and wider joint procurement of medicines outside emergency situations.
A report from the EU medicines regulatory network looks at what was done well in the response to the COVID-19 pandemic, and what needs to be improved if we are to be better prepared next time.